...
首页> 外文期刊>Oral diseases >An evaluation of vitamin E and pycnogenol in children suffering from oral mucositis during cancer chemotherapy
【24h】

An evaluation of vitamin E and pycnogenol in children suffering from oral mucositis during cancer chemotherapy

机译:癌症化疗期间口腔黏膜炎患儿的维生素E和碧萝ogen的评估

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The purpose of the present study was to evaluate and compare the effectiveness of Vitamin E (E) and Pycnogenol (P) in treatment of Chemotherapy-Related Oral Mucositis (ChROM) in children-. MATERIALS AND METHODS: A total of 72 children, aged between 6 and 15 years, with ChROM were selected and randomly divided into three groups after assessment of oral mucositis (OM) by WHO grading system. Glycerine (control), E, and P were topically applied in group I, II, and III, respectively, and the prognosis of OM was assessed by functional, objective, and subjective parameters. RESULTS: Patients of group II and III showed significant improvement when ChROM was analyzed through scoring systems - WHO grading, Oral Mucositis Assessment Scale (OMAS), and Children's International Mucositis Evaluation Scale (ChlMES) as compared to group I (P < 0.001); however, there was no significant difference between groups II and III.CONCLUSION: Both the drugs E and P per se are effective for treatment of OM with P being not effective for the treatment of severe mucositis (grade 4). Combination of E and P and additional agents may be tried for better results.
机译:目的:本研究的目的是评估和比较维生素E(E)和碧萝ogen(P)在儿童化疗相关的口腔粘膜炎(ChROM)中的疗效。材料与方法:经WHO分级系统评估口腔粘膜炎(OM)后,共选择72例6至15岁的ChROM儿童,并将其随机分为三组。甘油(对照),E和P分别应用于I,II和III组,并通过功能,客观和主观参数评估OM的预后。结果:通过评分系统对ChROM进行分析后,II组和III组患者显示出显着改善-与I组相比,WHO分级,口腔粘膜炎评估量表(OMAS)和儿童国际粘膜炎评估量表(ChlMES)(P <0.001);结论:药物E和P本身对OM均有效,而P对严重粘膜炎无效(4级)。可以尝试将E和P与其他试剂结合使用以获得更好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号